Joseph Scaduto, MS, MBA
Founder and CEO Traverse Biosciences, Inc. Co-Founder and CEO of CMTx Biotech Inc. CMTx Biotech Inc. is a clinical-stage biopharmaceutical company working to commercialize incyclinide for the treatment of hospitalized sepsis patients at risk for septic shock, acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS), including those afflicted with COVID-19. Mr. Scaduto is also the Founder and CEO of Traverse Biosciences Inc., an emerging bioscience company commercializing a proprietary library of novel drug candidates to treat chronic inflammatory conditions affecting humans and animals.He is also a Co-Founder and Managing Partner of Hairpin Technologies Inc., the exclusive licensing agent of Cold Spring Harbor Laboratory (CSHL) to expand the commercial distribution and use of small hairpin RNA (shRNA). Mr. Scaduto was previously designated as an external BioEntrepreneur-In-Residence (B-EIR) by the philanthropic Advisory Board of the Center for Biotechnology at Stony Brook University. He served previously as the Assistant Director of Business Development at the Center for Biotechnology, as well as the founding Executive Director of the Long Island Life Sciences Initiative (LILSI). He has over 20 years of experience providing business development expertise, strategic planning services and technology commercialization guidance to emerging and expanding bioscience companies.